Atara Jumps After Data Released On Multiple Sclerosis Study

Data, being presented at the virtual European Academy of Neurology meeting next week in a late-breaking abstract related to ATA188, an allogeneic cell therapy being developed by Atara Biotherapeutics, has been released.